Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Inject on the schedule the calculator returns above
Regarding FDA approval: because this is a compounded product, it is not directly FDA-approved
While each medication has its own side effect profile, their concurrent use may create additive or synergistic risks
minimal calcitonin receptor activity by design Dosing schedule Once weekly, subcutaneous Once weekly, subcutaneous Key monotherapy trial Phase 2 dose-finding, n=706
This is crucial context because it explains why AOD 9604 works better as part of a combination strategy rather than as a standalone fat loss solution
US$ 24.00
US$ 20.55
US$ 23.77
US$ 23.73
